BioStem Technologies, Inc. (BSEM)
5.21
-0.28
(-5.10%)
USD |
OTCM |
Mar 06, 16:00
BioStem Technologies SG&A Expense (TTM) : 206.49M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Plus Therapeutics, Inc. | 11.09M |
| Iovance Biotherapeutics, Inc. | 152.58M |
| Protokinetix, Inc. | 0.063M |
| GB Sciences, Inc. | 0.9456M |
| Travere Therapeutics, Inc. | 337.20M |